Sign In
Buy XFABF
X-fab Silicon Foundries Se Earnings Calls
| Release date | Jul 30, 2026 |
| EPS estimate | -$0.0650 |
| EPS actual | -$0.110 |
| EPS Surprise | -69.23% |
| Revenue estimate | 198.66M |
| Revenue actual | 196.281M |
| Revenue Surprise | -1.20% |
| Release date | Apr 30, 2026 |
| EPS estimate | -$0.0150 |
| EPS actual | $0.0100 |
| EPS Surprise | 166.67% |
| Revenue estimate | 217.79M |
| Revenue actual | 205.823M |
| Revenue Surprise | -5.49% |
| Release date | Feb 05, 2026 |
| EPS estimate | $0.0900 |
| EPS actual | $0.0100 |
| EPS Surprise | -88.89% |
| Revenue estimate | 229.416M |
| Revenue actual | 218.102M |
| Revenue Surprise | -4.93% |
| Release date | Oct 30, 2025 |
| EPS estimate | $0.0700 |
| EPS actual | $0.128 |
| EPS Surprise | 82.14% |
| Revenue estimate | 218.667M |
| Revenue actual | 229.522M |
| Revenue Surprise | 4.96% |
Last 4 Quarters for X-fab Silicon Foundries Se
Below you can see how XFABF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Oct 30, 2025 |
| Price on release | $7.75 |
| EPS estimate | $0.0700 |
| EPS actual | $0.128 |
| EPS surprise | 82.14% |
| Date | Price |
|---|---|
| Oct 24, 2025 | $7.75 |
| Oct 27, 2025 | $7.75 |
| Oct 28, 2025 | $7.75 |
| Oct 29, 2025 | $7.75 |
| Oct 30, 2025 | $7.75 |
| Oct 31, 2025 | $6.40 |
| Nov 03, 2025 | $6.15 |
| Nov 04, 2025 | $6.15 |
| Nov 05, 2025 | $6.15 |
| 4 days before | 0% |
| 4 days after | -20.65% |
| On release day | -17.42% |
| Change in period | -20.65% |
| Release date | Feb 05, 2026 |
| Price on release | $5.66 |
| EPS estimate | $0.0900 |
| EPS actual | $0.0100 |
| EPS surprise | -88.89% |
| Date | Price |
|---|---|
| Jan 30, 2026 | $6.15 |
| Feb 02, 2026 | $6.15 |
| Feb 03, 2026 | $5.66 |
| Feb 04, 2026 | $5.66 |
| Feb 05, 2026 | $5.66 |
| Feb 06, 2026 | $5.66 |
| Feb 09, 2026 | $5.17 |
| Feb 10, 2026 | $5.17 |
| Feb 11, 2026 | $5.17 |
| 4 days before | -7.97% |
| 4 days after | -8.66% |
| On release day | 0% |
| Change in period | -15.93% |
| Release date | Apr 30, 2026 |
| Price on release | $7.24 |
| EPS estimate | -$0.0150 |
| EPS actual | $0.0100 |
| EPS surprise | 166.67% |
| Date | Price |
|---|---|
| Apr 24, 2026 | $7.90 |
| Apr 27, 2026 | $8.00 |
| Apr 28, 2026 | $8.00 |
| Apr 29, 2026 | $7.90 |
| Apr 30, 2026 | $7.24 |
| May 01, 2026 | $7.24 |
| May 04, 2026 | $7.35 |
| May 05, 2026 | $7.35 |
| May 06, 2026 | $7.70 |
| 4 days before | -8.35% |
| 4 days after | 6.35% |
| On release day | 0% |
| Change in period | -2.53% |
| Release date | Jul 30, 2026 |
| Price on release | $8.10 |
| EPS estimate | -$0.0650 |
| EPS actual | -$0.110 |
| EPS surprise | -69.23% |
| Date | Price |
|---|---|
| Jul 24, 2026 | $8.10 |
| Jul 27, 2026 | $8.10 |
| Jul 28, 2026 | $8.10 |
| Jul 29, 2026 | $8.10 |
| Jul 30, 2026 | $8.10 |
| Jul 31, 2026 | $6.75 |
| Aug 03, 2026 | $6.75 |
| Aug 04, 2026 | $6.75 |
| Aug 05, 2026 | $6.75 |
| 4 days before | 0% |
| 4 days after | -16.67% |
| On release day | -16.67% |
| Change in period | -16.67% |
X-fab Silicon Foundries Se Earnings Call Transcript Summary of Q2 2026
X-FAB reported Q2 2026 revenue of $199.8M (down 7% YoY, +2% QoQ) and bookings of $173.3M with backlog of $291.8M. Underlying book-to-bill returned above 1.0 (excluding Erfurt end-of-life), suggesting demand stabilization. Core markets (automotive, industrial, medical) made up 93% of revenue; automotive remains weak (down 19% YoY) but bookings and design wins are improving. Medical and microsystems/photonic businesses showed strong growth (medical +39% YoY; microsystems & photonics +14% YoY). Wide bandgap (SiC/GaN) revenue up 34% YoY with new design wins. X-FAB won EUR 127.4M EU Chips Act funding for Erfurt expansion (Fab4Micro) to focus on MEMS, microfluidics and photonics; photonics volume production expected in 2028. Management highlights a strategic opportunity from AI/data-center demand across CMOS, photonics, SiC and GaN, estimating ~USD 300M long-term revenue potential, though current DC-related revenue is modest (~$20–30M). Q2 EBITDA was $33.6M (16.8% margin); adjusted margin (excluding revenue recognized over time) would be ~17.6%, within guidance. Cash was $163.6M, net debt $312.3M; H1 CapEx $50.2M. Q3 guidance: revenue $195–205M, EBITDA margin 17–20%. Management expects capacity utilization to gradually recover from ~60% toward target ~85%, believes current capacity sufficient for 2–3 years, and continues cost-control and cash preservation initiatives. Financial options include extending a revolving credit and exploring alternative financings to manage upcoming repayments.
